Cat. No.: DIA-0243277
Product Information | |
---|---|
CAS No. | 386704-15-0 |
Formula | C10H8F3NO3 |
Molecular Weight | 247.17 |
SMILES | COC(=O)CC(=O)C1=CN=C(C=C1)C(F)(F)F |
Target | 11β-HSD |
Product Description | 11β-HSD1-IN-8 (compound c6a) is a 11β‑HSD1 inhibitor with an IC50 value of 2.3 μM for human 11β‑HSD1. 11β-HSD1-IN-8 can be used for the research of diabetes and cognitive decline. |
Format & Storage | |
---|---|
Format | Solid |
Color | Off-white to light yellow |
Purity | ≥95.0% |
Shipping | Room temperature in the continental U.S. Other areas may vary. |
Storage | Powder: -20°C, 3 years; 4°C, 2 years In solvent: -80°C, 6 months; -20°C, 1 month |
Solubility Overview | Soluble in DMSO |
Ace Therapeutics has a team of experts in the field of endocrine and metabolic research, aiming to provide innovative preclinical contract research solutions to cope with diabetes and its complications. We provide customized solutions and technical support, enabling the transformation of promising concepts into innovative treatments, thus accelerating the drug development process of diabetes.